|
1
|
Robinson DR, Wu YM and Lin SF: The protein
tyrosine kinase family of the human genome. Oncogene. 19:5548–5557.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schlessinger J: Cell signaling by receptor
tyrosine kinases. Cell. 103:211–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Krause DS and Van Etten RA: Tyrosine
kinases as targets for cancer therapy. N Engl J Med. 353:172–187.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hafizi S and Dahlbäck B: Signalling and
functional diversity within the Axl subfamily of receptor tyrosine
kinases. Cytokine Growth Factor Rev. 17:295–304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Linger RM, Keating AK, Earp HS and Graham
DK: TAM receptor tyrosine kinases: Biologic functions, signaling,
and potential therapeutic targeting in human cancer. Adv Cancer
Res. 100:35–83. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Manfioletti G, Brancolini C, Avanzi G and
Schneider C: The protein encoded by a growth arrest-specific gene
(gas6) is a new member of the vitamin K-dependent proteins related
to protein S, a negative coregulator in the blood coagulation
cascade. Mol Cell Biol. 13:4976–4985. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schneider C, King RM and Philipson L:
Genes specifically expressed at growth arrest of mammalian cells.
Cell. 54:787–793. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goruppi S, Ruaro E and Schneider C: Gas6,
the ligand of Axl tyrosine kinase receptor, has mitogenic and
survival activities for serum starved NIH3T3 fibroblasts. Oncogene.
12:471–480. 1996.PubMed/NCBI
|
|
9
|
Berclaz G, Altermatt HJ, Rohrbach V,
Kieffer I, Dreher E and Andres AC: Estrogen dependent expression of
the receptor tyrosine kinase axl in normal and malignant human
breast. Ann Oncol. 12:819–824. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Craven RJ, Xu LH, Weiner TM, Fridell YW,
Dent GA, Srivastava S, Varnum B, Liu ET and Cance WG: Receptor
tyrosine kinases expressed in metastatic colon cancer. Int J
Cancer. 60:791–797. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hutterer M, Knyazev P, Abate A, Reschke M,
Maier H, Stefanova N, Knyazeva T, Barbieri V, Reindl M, Muigg A, et
al: Axl and growth arrest-specific gene 6 are frequently
overexpressed in human gliomas and predict poor prognosis in
patients with glioblastoma multiforme. Clin Cancer Res. 14:130–138.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Quong RY, Bickford ST, Ing YL, Terman B,
Herlyn M and Lassam NJ: Protein kinases in normal and transformed
melanocytes. Melanoma Res. 4:313–319. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sawabu T, Seno H, Kawashima T, Fukuda A,
Uenoyama Y, Kawada M, Kanda N, Sekikawa A, Fukui H, Yanagita M, et
al: Growth arrest-specific gene 6 and Axl signaling enhances
gastric cancer cell survival via Akt pathway. Mol Carcinog.
46:155–164. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shieh YS, Lai CY, Kao YR, Shiah SG, Chu
YW, Lee HS and Wu CW: Expression of axl in lung adenocarcinoma and
correlation with tumor progression. Neoplasia. 7:1058–1064. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brand-Saberi B, Müller TS, Wilting J,
Christ B and Birchmeier C: Scatter factor/hepatocyte growth factor
(SF/HGF) induces emigration of myogenic cells at interlimb level in
vivo. Dev Biol. 179:303–308. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hattori S, Kikuchi E, Kosaka T, Miyazaki
Y, Tanaka N, Miyajima A, Mikami S and Oya M: Relationship between
increased expression of the Axl/Gas6 signal cascade and prognosis
of patients with upper tract urothelial carcinoma. Ann Surg Oncol.
23:663–670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reichl P, Dengler M, van Zijl F, Huber H,
Führlinger G, Reichel C, Sieghart W, Peck-Radosavljevic M,
Grubinger M and Mikulits W: Axl activates autocrine transforming
growth factor-β signaling in hepatocellular carcinoma. Hepatology.
61:930–941. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brand TM, Iida M, Stein AP, Corrigan KL,
Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP,
et al: AXL is a logical molecular target in head and neck squamous
cell carcinoma. Clin Cancer Res. 21:2601–2612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dunne PD, McArt DG, Blayney JK, Kalimutho
M, Greer S, Wang T, Srivastava S, Ong CW, Arthur K, Loughrey M, et
al: AXL is a key regulator of inherent and chemotherapy-induced
invasion and predicts a poor clinical outcome in early-stage colon
cancer. Clin Cancer Res. 20:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee HJ, Jeng YM, Chen YL, Chung L and Yuan
RH: Gas6/Axl pathway promotes tumor invasion through the
transcriptional activation of Slug in hepatocellular carcinoma.
Carcinogenesis. 35:769–775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Debruyne DN, Bhatnagar N, Sharma B, Luther
W, Moore NF, Cheung NK, Gray NS and George RE: ALK inhibitor
resistance in ALK(F1174L)-driven neuroblastoma is associated with
AXL activation and induction of EMT. Oncogene. 35:3681–3691. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giles KM, Kalinowski FC, Candy PA, Epis
MR, Zhang PM, Redfern AD, Stuart LM, Goodall GJ and Leedman PJ: Axl
mediates acquired resistance of head and neck cancer cells to the
epidermal growth factor receptor inhibitor erlotinib. Mol Cancer
Ther. 12:2541–2558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Z, Lee JC, Lin L, Olivas V, Au V,
LaFramboise T, Abdel-Rahman M, Wang X, Levine AD, Rho JK, et al:
Activation of the AXL kinase causes resistance to EGFR-targeted
therapy in lung cancer. Nat Genet. 44:852–860. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Müller J, Krijgsman O, Tsoi J, Robert L,
Hugo W, Song C, Kong X, Possik PA, Cornelissen-Steijger PD, Foppen
Geukes MH, et al: Low MITF/AXL ratio predicts early resistance to
multiple targeted drugs in melanoma. Nat Commun. 5:57122014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Heymann S, Koudrova M, Arnold H, Köster M
and Braun T: Regulation and function of SF/HGF during migration of
limb muscle precursor cells in chicken. Dev Biol. 180:566–578.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Borowiak M, Garratt AN, Wüstefeld T,
Strehle M, Trautwein C and Birchmeier C: Met provides essential
signals for liver regeneration. Proc Natl Acad Sci USA.
101:10608–10613. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huh CG, Factor VM, Sánchez A, Uchida K,
Conner EA and Thorgeirsson SS: Hepatocyte growth factor/c-met
signaling pathway is required for efficient liver regeneration and
repair. Proc Natl Acad Sci USA. 101:4477–4482. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Di Renzo MF, Poulsom R, Olivero M,
Comoglio PM and Lemoine NR: Expression of the Met/hepatocyte growth
factor receptor in human pancreatic cancer. Cancer Res.
55:1129–1138. 1995.PubMed/NCBI
|
|
29
|
Lengyel E, Prechtel D, Resau JH, Gauger K,
Welk A, Lindemann K, Salanti G, Richter T, Knudsen B, Woude GF
Vande, et al: C-Met overexpression in node-positive breast cancer
identifies patients with poor clinical outcome independent of
Her2/neu. Int J Cancer. 113:678–682. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu C, Park M and Tsao MS: Overexpression
of c-met proto-oncogene but not epidermal growth factor receptor or
c-erbB-2 in primary human colorectal carcinomas. Oncogene.
7:181–185. 1992.PubMed/NCBI
|
|
31
|
Ramirez R, Hsu D, Patel A, Fenton C,
Dinauer C, Tuttle RM and Francis GL: Over-expression of hepatocyte
growth factor/scatter factor (HGF/SF) and the HGF/SF receptor
(cMET) are associated with a high risk of metastasis and recurrence
for children and young adults with papillary thyroid carcinoma.
Clin Endocrinol (Oxf). 53:635–644. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rho JK, Choi YJ, Kim SY, Kim TW, Choi EK,
Yoon SJ, Park BM, Park E, Bae JH, Choi CM, et al: MET and AXL
inhibitor NPS-1034 exerts efficacy against lung cancer cells
resistant to EGFR kinase inhibitors because of MET or AXL
activation. Cancer Res. 74:253–262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tokunou M, Niki T, Eguchi K, Iba S, Tsuda
H, Yamada T, Matsuno Y, Kondo H, Saitoh Y, Imamura H, et al: c-MET
expression in myofibroblasts: Role in autocrine activation and
prognostic significance in lung adenocarcinoma. Am J Pathol.
158:1451–1463. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsao MS, Liu N, Chen JR, Pappas J, Ho J,
To C, Viallet J, Park M and Zhu H: Differential expression of
Met/hepatocyte growth factor receptor in subtypes of non-small cell
lung cancers. Lung Cancer. 20:1–16. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma PC, Jagadeeswaran R, Jagadeesh S,
Tretiakova MS, Nallasura V, Fox EA, Hansen M, Schaefer E, Naoki K,
Lader A, et al: Functional expression and mutations of c-Met and
its therapeutic inhibition with SU11274 and small interfering RNA
in non-small cell lung cancer. Cancer Res. 65:1479–1488. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wimmel A, Glitz D, Kraus A, Roeder J and
Schuermann M: Axl receptor tyrosine kinase expression in human lung
cancer cell lines correlates with cellular adhesion. Eur J Cancer.
37:2264–2274. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Salian-Mehta S, Xu M and Wierman ME: AXL
and MET crosstalk to promote gonadotropin releasing hormone (GnRH)
neuronal cell migration and survival. Mol Cell Endocrinol.
374:92–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim HR, Kim WS, Choi YJ, Choi CM, Rho JK
and Lee JC: Epithelial-mesenchymal transition leads to crizotinib
resistance in H2228 lung cancer cells with EML4-ALK translocation.
Mol Oncol. 7:1093–1102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Y, Ye X, Tan C, Hongo JA, Zha J, Liu J,
Kallop D, Ludlam MJ and Pei L: Axl as a potential therapeutic
target in cancer: Role of Axl in tumor growth, metastasis and
angiogenesis. Oncogene. 28:3442–3455. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Organ SL and Tsao MS: An overview of the
c-MET signaling pathway. Ther Adv Med Oncol. 3:(Suppl). S7–S19.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sierra JR and Tsao MS: c-MET as a
potential therapeutic target and biomarker in cancer. Ther Adv Med
Oncol. 3:(Suppl). S21–S35. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gujral TS, Karp RL, Finski A, Chan M,
Schwartz PE, MacBeath G and Sorger P: Profiling phospho-signaling
networks in breast cancer using reverse-phase protein arrays.
Oncogene. 32:3470–3476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Freudlsperger C, Alexander D, Reinert S
and Hoffmann J: Prognostic value of c-Met expression in oral
squamous cell carcinoma. Exp Ther Med. 1:69–72. 2010.PubMed/NCBI
|
|
45
|
Gisterek I, Lata E, Halon A, Matkowski R,
Szelachowska J, Biecek P and Kornafel J: Prognostic role of c-met
expression in breast cancer patients. Rep Pract Oncol Radiother.
16:173–177. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ishikawa M, Sonobe M, Nakayama E,
Kobayashi M, Kikuchi R, Kitamura J, Imamura N and Date H: Higher
expression of receptor tyrosine kinase Axl, and differential
expression of its ligand, Gas6, predict poor survival in lung
adenocarcinoma patients. Ann Surg Oncol. 20:(Suppl 3). S467–S476.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lee CH, Yen CY, Liu SY, Chen CK, Chiang
CF, Shiah SG, Chen PH and Shieh YS: Axl is a prognostic marker in
oral squamous cell carcinoma. Ann Surg Oncol. 19:(Suppl 3).
S500–S508. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pinato DJ, Mauri FA, Lloyd T, Vaira V,
Casadio C, Boldorini RL and Sharma R: The expression of Axl
receptor tyrosine kinase influences the tumour phenotype and
clinical outcome of patients with malignant pleural mesothelioma.
Br J Cancer. 108:621–628. 2013. View Article : Google Scholar : PubMed/NCBI
|
